Empyema Thoracis In Children-A Study From Tertiary Care Hospital
DOI:
https://doi.org/10.61841/dct93782Keywords:
Empyema, Thoracis, ChildrenAbstract
Aims and objectives –to know clinical profile,antibiotic sensitivity of organisms and effectiveness of medical therapy and pleural drainage in managing empyema in childrenMethods- Prospective cohort studySetting-Krishna hospital,KaradPatients-30 children between 6 months-13 years admitted with empyema from March 2018-February 2019 were studied and data was analysed using appropriate statistical methods.Results– During the study period, 30 children (20 males) were identified with empyema with a median (range) age at presentation of 4 years (6 months-13 years). Fever, dyspnea and cough were the most common (90%) manifestations at admission. Median (range) duration of fever was 10 days (5 days - 1month). The pleural fluid aspirated was thick pus in 80%; pleural fluid sugars were less than 40 mg/dL in 75% samples. Pleural liquid culture developed Staphylococcus aureus in 7 youngsters, and Streptococcus pneumoniae in 1 kid. Blood culture was certain just for one patient. 25 patients(84%) indicated clinical improvement after the beginning of anti-infection agents. In many patients (56%) fever died down inside 5 days after confirmation with a middle length of 4 days. The middle span of respiratory pain during medical clinic remain was 6 days. 5 patients got the second line anti-infection agents following five days of confirmation. 20 (68%) patients got anti-infection agents (oral in addition to parenteral) for about a month and 12% for a period more noteworthy than about a month and a half. The middle length of chest tube inclusion was 8 days, however 4 patients had drawn out chest tube seepage (2 indicated deferred response,2 created bronchopleural fistula). Three patients required more than one chest tube taking into account loculated effusion. The minimum duration of hospital stay to complete the course of injectable antibiotics was 14 days.Conclusion- Fitting anti-infection agents and brief chest tube drainage is a powerful strategy for treatment of youth empyema, particularly in asset poor settings.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.